Investors.avadel.com

The medical condition 72 percent of Americans don’t …

WebOver one-third of Americans wake up more than once per night to urinate due to a condition called nocturia, which can cause daytime tiredness and irritability, …

Actived: 7 days ago

URL: https://investors.avadel.com/news-releases/news-release-details/medical-condition-72-percent-americans-dont-know-about-stealing

Avadel Pharmaceuticals Provides Corporate Update and …

Web-- Generated $27.2 million in net revenue from sales of LUMRYZ™ ---- Through March 31, greater than 2,800 patients enrolled in Avadel’s RYZUP patient support …

Category:  Health Go Health

Quarterly Results Avadel Pharmaceuticals PLC

WebThe Investor Relations website contains information about Avadel Pharmaceuticals PLC's business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

Avadel Launches NOCTIVA™, the First and Only FDA …

WebInnovative product now available in the United States for condition that interrupts sleep for over 40 million Americans. DUBLIN, Ireland, May 01, 2018 (GLOBE …

Category:  Health Go Health

Avadel Pharmaceuticals Appoints Dr. Douglas Williamson …

WebDUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today …

Category:  Medicine Go Health

Avadel Pharmaceuticals Provides Corporate Update and …

WebFDA review of NDA for FT218 is ongoing; commercial and launch preparations on-track to support potential commercial launch Expanded the robust …

Category:  Health Go Health

Avadel Pharmaceuticals Announces Final FDA Approval of …

Web- Granted Orphan Drug Exclusivity through May 1, 2030 - -Advanced commercial preparations on track; LUMRYZ product availability expected in early June - …

Category:  Health Go Health

Avadel Pharmaceuticals Further Strengthens Clinical and …

WebContacts: Michael F. Kanan Chief Financial Officer Phone: (636) 449-1844 Email: [email protected] Lee Roth Burns McClellan Phone: (212) 213-0006

Category:  Health Go Health

Avadel Pharmaceuticals Announces Data Supporting …

WebIn addition to Avadel’s oral and poster presentations, the Company will support a symposium titled “Addressing Unmet Medical Needs and Introduction of …

Category:  Medical Go Health

Avadel Pharmaceuticals Announces Promotion of Gregory …

WebDUBLIN, Ireland, March 22, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), “Avadel” or the “Company,” today announced the promotion of …

Category:  Health Go Health

Avadel Pharmaceuticals Announces Data Supporting Clinical …

WebIn addition to Avadel’s oral and poster presentations, the Company will support a symposium for U.S. healthcare professionals titled “Evolving the Therapeutic …

Category:  Health Go Health

Board of Directors Avadel Pharmaceuticals PLC

WebChairman of the Board. Geoffrey M. Glass has been a member of the Avadel Board of Directors since July 2018 and became Chairman of the Board in December 2018. Geoff …

Category:  Health Go Health

Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive

WebDUBLIN, Ireland, June 03, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for narcolepsy, today …

Category:  Health Go Health

Avadel Pharmaceuticals Appoints Gregory J. Divis Chief …

WebDUBLIN, Ireland, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL) today announced the addition of Gregory J. Divis as Executive Vice …

Category:  Health Go Health

Avadel Pharmaceuticals Provides Corporate Update and Reports …

Web-- Generated $19.5 million in fourth quarter and $28.0 million of full year 2023 net revenue from sales of LUMRYZ™ ---- As of January 31 st, greater than 2,200 …

Category:  Health Go Health

Linda Palczuk Board Member Avadel Pharmaceuticals PLC

WebLinda S. Palczuk has been a member of the Avadel Board of Directors since July 2018. Since September 2019, Linda has been the Chief Operating Officer and a Director of …

Category:  Health Go Health

Gregory Divis Board Member Avadel Pharmaceuticals PLC

WebGregory J. Divis serves as Avadel’s Chief Executive Officer and a member of our Board of Directors. Greg was appointed CEO in June of 2019, after previously serving in several …

Category:  Health Go Health

Avadel Pharmaceuticals Announces Strong LUMRYZ Launch …

Web-- Approximately $19 million and $28 million of net revenue from sales of LUMRYZ™ estimated for the fourth quarter and full year 2023, respectively ---- …

Category:  Health Go Health